share_log

四環醫藥：董事會會議通知

SIHUAN PHARM: NOTICE OF BOARD MEETING

香港交易所 ·  Mar 18 16:31
Summary by Futu AI
四環醫藥控股集團有限公司（「四環醫藥」）將於2024年3月28日（星期四）召開董事會會議，主要目的是批准及發佈截至2023年12月31日止年度的業績報告，並將考慮是否派發末期股息。該會議由公司主席兼執行董事車馮升醫生主持，並於2024年3月18日向公眾宣佈。四環醫藥的董事會成員包括執行董事及獨立非執行董事，他們將一同參與會議並作出決策。
四環醫藥控股集團有限公司（「四環醫藥」）將於2024年3月28日（星期四）召開董事會會議，主要目的是批准及發佈截至2023年12月31日止年度的業績報告，並將考慮是否派發末期股息。該會議由公司主席兼執行董事車馮升醫生主持，並於2024年3月18日向公眾宣佈。四環醫藥的董事會成員包括執行董事及獨立非執行董事，他們將一同參與會議並作出決策。
Four Circle Pharmaceutical Holdings Group Limited (“Four Circle Pharmaceuticals”) will hold a Board Meeting on Thursday, March 28, 2024. The primary purpose of which will be to approve and publish the results report for the year ended December 31, 2023, and consideration will be given to the distribution of a final dividend. The meeting was hosted by Dr. Che Feng Sheng, Chairman and Executive Director, and announced to the public on 18 March 2024. The board members of Four Circle Pharmaceuticals include executive directors and independent non-executive directors, who will participate in meetings and make decisions together.
Four Circle Pharmaceutical Holdings Group Limited (“Four Circle Pharmaceuticals”) will hold a Board Meeting on Thursday, March 28, 2024. The primary purpose of which will be to approve and publish the results report for the year ended December 31, 2023, and consideration will be given to the distribution of a final dividend. The meeting was hosted by Dr. Che Feng Sheng, Chairman and Executive Director, and announced to the public on 18 March 2024. The board members of Four Circle Pharmaceuticals include executive directors and independent non-executive directors, who will participate in meetings and make decisions together.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.